Fuji Pharma Co Ltd
TSE:4554
Fuji Pharma Co Ltd
EPS (Diluted)
Fuji Pharma Co Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fuji Pharma Co Ltd
TSE:4554
|
EPS (Diluted)
¥208
|
CAGR 3-Years
34%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
EPS (Diluted)
¥112
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-5%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
EPS (Diluted)
¥96
|
CAGR 3-Years
39%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-5%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
EPS (Diluted)
¥253
|
CAGR 3-Years
-4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-1%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
EPS (Diluted)
¥197
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
8%
|
|
Astellas Pharma Inc
TSE:4503
|
EPS (Diluted)
¥20
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-7%
|
See Also
What is Fuji Pharma Co Ltd's EPS (Diluted)?
EPS (Diluted)
208.2
JPY
Based on the financial report for Dec 31, 2023, Fuji Pharma Co Ltd's EPS (Diluted) amounts to 208.2 JPY.
What is Fuji Pharma Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
11%
Over the last year, the EPS (Diluted) growth was 88%. The average annual EPS (Diluted) growth rates for Fuji Pharma Co Ltd have been 34% over the past three years , 14% over the past five years , and 11% over the past ten years .